NIOSH updates hazardous drugsNo abstract available.Hospital Employee Health
2022最新美国cdcniosh危险药品目录最新完整版本.pdf,NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2010 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Institute for Occupational Saf
Since most of the research on the environmental presence and ecotoxicological effects of pharmaceuticals has been focused on this therapeutic class (studies have been performed with drugs pertaining to “L” ATC code), other “hazardous”, carcinogenic drugs belonging to different therapeutic groups may...
NIOSH alerts healthcare professionals to antineoplastic and other hazardous drugs in healthcare settingsFrom the National Institute for Occupational Safety and Healthdoi:http://drugtopics.modernmedicine.com/node/114886Drug Topics staffAdvanstar Communications Inc...
Gap Analysis Helps Organizations Integrate Three Key Documents—In September 2004, the National Institute for Occupational Safety and Health (NIOSH) published an alert entitled "Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Healthcare Settings." The alert contains five ...
Preventing Exposure to Hazardous Drugs: Engineering-Control Recommendations in the NIOSH AlertDuane Hammond, a mechan- ical engineer for NIOSH in Cincinnati, Ohio, has been conducting occupational health research at NIOSH for three years, focusing on evaluating the effectiveness of engineering controls ...
The article offers information on a new document presented by National Institute for Occupational Safety and Health (NIOSH) of the U.S. that addresses medical surveillance for workers of pharmaceutical industry who are exposed to hazardous drugs....
professional organizations and academia to achieve these goals. Approaches related to NIOSH's goals have included: method development for sampling and analysis of hazardous drugs; field studies to evaluate worker exposure; and development of several guidance documents related to hazardous drug exposure. ...
In June 2012, the National Institute for Occupational Safety and Health (NIOSH) published the "NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012. The document builds on a NIOSH alert from 2004 that warned health care employers and workers of the risks of working...
FDA on July 23 approved aclidinium bromide oral inhalation powder for long-term maintenance therapy in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.Forest Laboratories Inc. will market aclidinium as Tudorza Pressair, a combination of drug and a breath-...